Some biological features of Proteus bacilli. 2. Haemolytic activities of Proteus mirabilis and Proteus vulgaris strains
- PMID: 6202102
Some biological features of Proteus bacilli. 2. Haemolytic activities of Proteus mirabilis and Proteus vulgaris strains
Abstract
The haemolytic activities of Proteus mirabilis and P. vulgaris strains were studied under different conditions. No filterable alpha haemolysin could be detected in P. mirabilis uropathogens provided from patients with urinary tract infections. Together with the results presented in the accompanying paper, in which three clinical isolates with temporary ability to produce a soluble haemolysin were described, the occurrence of alpha haemolytic P. mirabilis isolates did not exceed 3%. Cell bound beta haemolysin is present in nearly 35% of P. mirabilis urinary strains. Another kind of haemolytic activity was observed when P. mirabilis and P. vulgaris strains were grown in liquid media supplemented with erythrocytes. During the logarithmic growth phase nearly 100% of P. mirabilis and P. vulgaris strains of various origin haemolyzed 100-50% of erythrocytes. Except for Serratia, the other representatives of Enterobacteriaceae did not demonstrate such activity in the same conditions. The preliminary characteristics of this phenomenon is given.
Similar articles
-
Some biological features of proteus bacilli. 3. Comparison of haemolytic activity of Proteus and Serratia strains.Acta Microbiol Pol. 1986;35(1-2):57-9. Acta Microbiol Pol. 1986. PMID: 2426926
-
Some biological features of Proteus bacilli. 1. Comparison of Proteus mirabilis strains provided from various sources.Acta Microbiol Pol. 1983;32(4):339-44. Acta Microbiol Pol. 1983. PMID: 6202101
-
Production and properties of haemolysins from clinical isolates of the Proteeae.J Med Microbiol. 1988 Jan;25(1):17-25. doi: 10.1099/00222615-25-1-17. J Med Microbiol. 1988. PMID: 3275780
-
Proteus virulence: involvement of the pore forming alpha-hemolysin (a short review).Acta Microbiol Immunol Hung. 2000;47(4):457-70. Acta Microbiol Immunol Hung. 2000. PMID: 11056765 Review.
-
Virulence determinants of uropathogenic Escherichia coli and Proteus mirabilis.Kidney Int Suppl. 1994 Nov;47:S129-36. Kidney Int Suppl. 1994. PMID: 7869662 Review.
Cited by
-
The HpmA hemolysin is more common than HlyA among Proteus isolates.Infect Immun. 1990 Jun;58(6):1853-60. doi: 10.1128/iai.58.6.1853-1860.1990. Infect Immun. 1990. PMID: 2341181 Free PMC article.
-
Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis.Clin Microbiol Rev. 2008 Jan;21(1):26-59. doi: 10.1128/CMR.00019-07. Clin Microbiol Rev. 2008. PMID: 18202436 Free PMC article. Review.
-
Professor Krystyna Kotełko and her contribution to the study of Proteus endotoxin.Innate Immun. 2018 Apr;24(3):148-151. doi: 10.1177/1753425918763066. Innate Immun. 2018. PMID: 29635980 Free PMC article.
-
Vaccination with proteus toxic agglutinin, a hemolysin-independent cytotoxin in vivo, protects against Proteus mirabilis urinary tract infection.Infect Immun. 2009 Feb;77(2):632-41. doi: 10.1128/IAI.01050-08. Epub 2008 Nov 24. Infect Immun. 2009. PMID: 19029299 Free PMC article.
-
Potential virulence factors of Proteus bacilli.Microbiol Mol Biol Rev. 1997 Mar;61(1):65-89. doi: 10.1128/mmbr.61.1.65-89.1997. Microbiol Mol Biol Rev. 1997. PMID: 9106365 Free PMC article. Review.